Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

Overview of attention for article published in Arthritis Research & Therapy, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 3 news outlets
policy: 1 policy source

twitter: 12 X users
facebook: 1 Facebook page

Readers on

mendeley: 76 Mendeley

Summary News Policy documents X Facebook

So far, Altmetric has seen 3 news stories from 3 outlets.

Artrite idiopatica giovanile, conferme real world per tocilizumab e inibitori IL-1

Pharmastar Italy, 07 Dec 2017

Stando ai risultati di uno studio pubblicato su Arthritis Research

Tocilizumab, IL-1 inhibitors yield 'significant response' for systemic juvenile idiopathic arthritis

Healio.com, 01 Dec 2017

Gerd Horneff A large segment of patients with systemic onset juvenile idiopathic arthritis experienced a significant response…

Tocilizumab, IL-1 inhibitors yield 'significant response' for systemic juvenile idiopathic arthritis

Bioportfolio, 01 Dec 2017

Gerd Horneff A large segment of patients with systemic onset juvenile idiopathic arthritis experienced a significant response…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.